Suppr超能文献

MRI-超声融合引导模板系统性前列腺穿刺活检与经直肠超声引导徒手系统性前列腺穿刺活检的前列腺癌检出率比较

A Comparison of Cancer Detection Rates Between Template Systematic Biopsies Obtained Using Magnetic Resonance Imaging-Ultrasound Fusion Machine and Freehand Transrectal Ultrasound-Guided Systematic Biopsies.

机构信息

Division of Urology, Department of Surgery, and University of Cincinnati, Cincinnati, Ohio, USA.

Division of Biostatistics and Bioinformatics, and University of Cincinnati, Cincinnati, Ohio, USA.

出版信息

J Endourol. 2020 Oct;34(10):1095-1098. doi: 10.1089/end.2020.0299. Epub 2020 Sep 21.

Abstract

There are reports that the 12-core template systematic biopsies (SBx) obtained by using software registration machines (e.g., Artemis) have higher cancer detection rates (CDRs) of prostate cancer (PCa) than the standard, freehand 12-core transrectal ultrasound (TRUS)-guided biopsies. The goal of our study is to compare the clinically significant (CS) CDRs of SBx in two independent cohorts who underwent freehand TRUS-SBx alone (Cohort A) or machine-guided SBx as part of a combined MRI-ultrasound (MRI-US) fusion biopsy (FBx) (Cohort B). A retrospective review of all patients undergoing prostate biopsies over a 4-year period at the University of Cincinnati Medical Center was performed. CS cancer was defined as having a Gleason score ≥7. MRI-US FBx were obtained by using an Artemis software registration device (ARTEMIS™, Eigen, Inc., Grass Valley, CA). Statistical significance was considered at  < 0.05. Nine hundred and thirty men underwent SBx (Cohort A: 474, Cohort B: 456). There were no statistical differences between cohort A and B in CS CDRs in the overall population (39.3% 33.8%;  = 0.093), biopsy naive patients (40.4% 39.8%;  = 0.951), or patients with a prior negative biopsy (22.7% 25.0%;  = 0.910). Multivariate logistic regression controlling for age, race, prostate-specific antigen level, prostate volume, abnormal digital rectal exam, and family history of PCa demonstrated comparable CS CDRs, which was maintained when further stratified by prior biopsy history (all patients: odds ratio [OR] 0.99, 95% confidence interval [CI] 0.71-1.38,  = 0.958; biopsy naive: OR 0.79, 95% CI 0.51-1.22,  = 0.291; prior negative biopsy: OR 0.64, 95% CI 0.21-1.75,  = 0.403). Our study did not find a significant difference in the CS CDRs of machine-guided SBx compared with the freehand TRUS-SBx. Unless the SBx is done at the time of FBx, the use of these machines for obtaining SBx only is unlikely to result in any increase of CS CDRs.

摘要

有报道称,使用软件注册机(如 Artemis)获得的 12 核模板系统活检(SBx)比标准的徒手经直肠超声(TRUS)引导的 12 核活检具有更高的前列腺癌(PCa)检出率(CDR)。我们的研究目的是比较两个独立队列中 SBx 的临床显著(CS)CDR,这些队列分别接受了徒手 TRUS-SBx (队列 A)或机器引导的 SBx 作为 MRI-超声(MRI-US)融合活检(FBx)的一部分(队列 B)。回顾性分析了在辛辛那提大学医疗中心进行前列腺活检的 4 年内的所有患者。CS 癌定义为 Gleason 评分≥7。MRI-US FBx 使用 Artemis 软件注册设备(ARTEMIS™,Eigen,Inc.,Grass Valley,CA)获得。统计学意义的临界值为  < 0.05。930 名男性接受了 SBx(队列 A:474 名,队列 B:456 名)。在总人群中,队列 A 和 B 的 CS CDR 之间没有统计学差异(39.3% 33.8%;  = 0.093),在初诊患者(40.4% 39.8%;  = 0.951)或既往阴性活检患者(22.7% 25.0%;  = 0.910)中也没有统计学差异。多变量逻辑回归控制年龄、种族、前列腺特异性抗原水平、前列腺体积、异常数字直肠检查和前列腺癌家族史后,CS CDR 具有可比性,当进一步按既往活检史分层时,这种情况仍得以维持(所有患者:比值比 [OR] 0.99,95%置信区间 [CI] 0.71-1.38,  = 0.958;初诊患者:OR 0.79,95% CI 0.51-1.22,  = 0.291;既往阴性活检患者:OR 0.64,95% CI 0.21-1.75,  = 0.403)。我们的研究没有发现机器引导的 SBx 与徒手 TRUS-SBx 的 CS CDR 之间有显著差异。除非 SBx 是在 FBx 时进行的,否则仅使用这些机器获取 SBx 不太可能导致 CS CDR 的任何增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验